Cancer Vaccines

Antibodies Against Breast Tumor Antigen Discovered

Published in Vaccine Weekly, March 29th, 2000

Specific circulating antibodies (Ab) to the breast cancer antigen GCDFP-15/gp17 were detected by an ELISA assay, reported researchers from Italy.

"Determination of circulating antibodies against tumor neoantigens is important for the development of preventive or therapeutic vaccines," noted R. Pasquinelli and colleagues from the Istituto Internazionale di Genetica e Biofisica, Italy. "We report here the finding of antibodies against the breast tumor antigen GCDFP-15/gp17."

Pasquinelli et al. presented data from their study at the 1st International Conference and 5th Annual Meeting of the International Society of Cancer Chemoprevention: Tumor...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-03-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry